Virpax Pharmaceuticals Ownership | Who Owns Virpax Pharmaceuticals?


OverviewFinancialsChart

Virpax Pharmaceuticals Ownership Summary


Virpax Pharmaceuticals is owned by 2.57% insiders, and 97.43% retail investors. Fidelity Extended Market Index is the top mutual fund, with 0.14% of its assets in Virpax Pharmaceuticals shares.

VRPX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockVirpax Pharmaceuticals-2.57%97.43%
SectorHealthcare Stocks 57.43%9.41%33.16%
IndustryBiotech Stocks 69.02%8.92%22.06%

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20241-1--1000000.00%----100.00%
Mar 31, 20241-94.12%1-100.00%----100.00%1-
Dec 31, 20231741.67%377,134-38.84%311.62%11266.67%1-66.67%
Sep 30, 202312-7.69%616,674-19.42%512.33%350.00%3-
Jun 30, 202313-18.75%765,295-31.24%67.24%2-33.33%3-40.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Extended Market Index25.31K0.14%-
Fidelity Total Market Index8.76K0.05%-
Fidelity Series Total Market Index6.86K0.04%-
Vanguard Institutional Extnd Mkt Idx Tr6.63K0.04%-
Fidelity Nasdaq Composite Index641.000.01%-
NT Ext Equity Mkt Idx Fd - NL949.000.01%-
NT Ext Equity Mkt Idx Fd - DC - NL - T2752.000.01%-12.00
NT Ext Equity Mkt Idx Fd - L573.000.00%-
Spartan Extended Market Index Pool E646.000.00%-
Northern Trust Extended Eq Market Idx573.000.00%-

Recent Insider Transactions


DateNameRoleActivityValue
May 24, 2022Sendrow Jerrold Buy$5.80K
May 18, 2022Mack Anthony P. Chief Executive OfficerBuy$101.50K
May 18, 2022Floyd Eric Buy$6.11K
Nov 22, 2021Sendrow Jerrold-Buy$15.31K
Nov 18, 2021Mack Anthony P. Chief Executive OfficerBuy$100.25K

Insider Transactions Trends


DateBuySell
2024 Q1--
2023 Q2--
2023 Q1--
2022 Q23-
2022 Q1--

VRPX Ownership FAQ


Who Owns Virpax Pharmaceuticals?

Virpax Pharmaceuticals shareholders are primarily institutional investors at 0.00%, followed by 2.57% insiders and 97.43% retail investors. The average institutional ownership in Virpax Pharmaceuticals's industry, Biotech Stocks , is 69.02%, which Virpax Pharmaceuticals falls below.

Does Blackrock own Virpax Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Virpax Pharmaceuticals.

Who is the top mutual fund holder of Virpax Pharmaceuticals shares?

Fidelity Extended Market Index is the top mutual fund holder of Virpax Pharmaceuticals shares, with 0.14% of its total shares outstanding invested in 25.31K Virpax Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools